Full name
GRUPA MPS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
68.10.Z - Real estate activities on own account and development of building projects
68.20.Z - Rental and management of own or leased real estate
82.99.Z - Other business support activities, not elsewhere classified
45.20.Z
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,2 | 0,3 | 0,4 | 17,5 |
Gross profit (loss) | 0,5 | 0,5 | 0,5 | 17,4 |
EBITDA | 0,5 | 0,5 | 0,6 | 18,6 |
Short time liabilities | 0,5 | 0,6 | 0,7 | 22,6 |
Other operating costs | 0 | 0 | 0 | 107,1 |
Equity capital | 0,5 | 0,9 | 1,5 | 57,8 |
Operating profit (EBIT) | 0,5 | 0,5 | 0,6 | 18,8 |
Assets | 0,9 | 1,5 | 2,2 | 44,8 |
Net profit (loss) | 0,4 | 0,5 | 0,5 | 17,4 |
Cash | 0,2 | 0,8 | 1,2 | 51,8 |
Liabilities and provisions for liabilities | 0,5 | 0,6 | 0,7 | 22,6 |
Net income from sale | 4,8 | 6,3 | 7,4 | 17,7 |
Working assets | 0,8 | 1,3 | 2 | 50,6 |
Other income costs | 0,3 | 0,2 | 0,2 | 25,1 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 90 | 49,2 | 36,6 | -12,6 |
Equity capital to total assets | 51 | 62,9 | 68,6 | 5,7 |
Gross profit margin | 9,6 | 7,4 | 7,4 | 0 |
EBITDA Margin | 10,1 | 7,8 | 7,8 | 0 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 35 | 32 | 34 | 2 |
Current financial liquidity indicator | 1.6732563972473145 | 2.3982441425323486 | 2.9469077587127686 | 0,5 |
Net dept to EBITDA | -0.4334160089492798 | -1.5810338258743286 | -2.0352463722229004 | -0,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane